Disclosure Declaration: Matthew A. Menza, MD, has declared the following financial relationships: Research Support, National Institutes of Health (NINDS), Parkinson’s Study Group (PSG), Pfizer/Wyeth, and Novartis. Consultant, National Institutes of Health (NINDS), National Institute of Mental Health, Otsuka. He will discuss an unapproved/uninvestigated use of a commercial product in his presentation (Antipsychotics in impulse control disorders). Jacob J Lindenthal, PhD, DrPH, Douglas Opler, MD, planning committee members, have no relevant financial relationships.
No takes yet. Share an insight, caveat, or question.
Matthew Menza (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Psychiatric Annals